Phorbol_NN
ester-induced_JJ
mononuclear_JJ
cell_NN
differentiation_NN
is_VBZ
blocked_VBN
by_IN
the_DT
mitogen-activated_JJ
protein_NN
kinase_NN
kinase_NN
-LRB-_-LRB-
MEK_NN
-RRB-_-RRB-
inhibitor_NN
PD98059_NN
._.

The_DT
purpose_NN
of_IN
this_DT
study_NN
was_VBD
to_TO
evaluate_VB
whether_IN
the_DT
mitogen-activated_JJ
protein_NN
kinase_NN
-LRB-_-LRB-
MAPK_NN
-RRB-_-RRB-
signaling_NN
pathway_NN
contributes_VBZ
to_TO
12-O-tetradecanoylphorbol-13-acetate_NN
-LRB-_-LRB-
TPA_NN
-RRB-_-RRB-
-_:
induced_JJ
mononuclear_JJ
differentiation_NN
in_IN
the_DT
human_JJ
myeloblastic_JJ
leukemia_NN
ML-1_NN
cells_NNS
._.

Upon_IN
TPA_NN
treatment_NN
,_,
the_DT
activity_NN
of_IN
ERK1_NN
and_CC
ERK2_NN
rapidly_RB
increased_VBD
,_,
with_IN
maximal_JJ
induction_NN
between_IN
1_CD
and_CC
3_CD
h_NN
,_,
while_IN
ERK2_NN
protein_NN
levels_NNS
remained_VBD
constant_JJ
._.

The_DT
activity_NN
of_IN
JNK1_NN
was_VBD
also_RB
significantly_RB
induced_JJ
,_,
with_IN
JNK1_NN
protein_NN
levels_NNS
increasing_VBG
moderately_RB
during_IN
exposure_NN
to_TO
TPA_NN
._.

Treatment_NN
of_IN
cells_NNS
with_IN
PD98059_NN
,_,
a_DT
specific_JJ
inhibitor_NN
of_IN
mitogen-activated_JJ
protein_NN
kinase_NN
kinase_NN
-LRB-_-LRB-
MEK_NN
-RRB-_-RRB-
,_,
inhibited_VBD
TPA-induced_JJ
ERK2_NN
activity_NN
._.

Furthermore_RB
,_,
PD98059_NN
completely_RB
blocked_VBD
the_DT
TPA-induced_JJ
differentiation_NN
of_IN
ML-1_NN
cells_NNS
,_,
as_IN
assessed_VBN
by_IN
a_DT
number_NN
of_IN
features_NNS
associated_VBN
with_IN
mononuclear_JJ
differentiation_NN
including_VBG
changes_NNS
in_IN
morphology_NN
,_,
nonspecific_JJ
esterase_NN
activity_NN
,_,
phagocytic_JJ
ability_NN
,_,
NADPH_NN
oxidase_NN
activity_NN
,_,
mitochondrial_JJ
respiration_NN
,_,
and_CC
c-jun_NN
mRNA_NN
inducibility_NN
._.

We_PRP
conclude_VBP
that_IN
activation_NN
of_IN
the_DT
MEK\/ERK_NN
signaling_NN
pathway_NN
is_VBZ
necessary_JJ
for_IN
TPA-induced_JJ
mononuclear_JJ
cell_NN
differentiation_NN
._.

